Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Phreesia Inc (PHR)

Phreesia Inc (PHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,215,655
  • Shares Outstanding, K 59,914
  • Annual Sales, $ 419,810 K
  • Annual Income, $ -58,530 K
  • EBIT $ 2 M
  • EBITDA $ 32 M
  • 60-Month Beta 0.64
  • Price/Sales 2.93
  • Price/Cash Flow N/A
  • Price/Book 4.13

Options Overview Details

View History
  • Implied Volatility 66.14% (-1.23%)
  • Historical Volatility 33.66%
  • IV Percentile 81%
  • IV Rank 52.01%
  • IV High 89.91% on 11/17/25
  • IV Low 40.39% on 07/17/25
  • Expected Move (DTE 12) 2.21 (10.89%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 807
  • Volume Avg (30-Day) 107
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 6,176
  • Open Int (30-Day) 5,899
  • Expected Range 18.08 to 22.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 4
  • High Estimate 0.03
  • Low Estimate -0.02
  • Prior Year -0.25
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.55 +9.38%
on 11/19/25
23.31 -12.94%
on 11/12/25
-2.38 (-10.50%)
since 11/05/25
3-Month
18.55 +9.38%
on 11/19/25
28.89 -29.77%
on 09/08/25
-7.84 (-27.87%)
since 09/05/25
52-Week
18.55 +9.38%
on 11/19/25
32.76 -38.06%
on 08/28/25
-0.84 (-3.98%)
since 12/05/24

Most Recent Stories

More News
Phreesia’s Megan Turco Named to MM+M 40 Under 40

Phreesia today announced that Megan Turco, Director of Client Experience for Phreesia Network Solutions, has been named to MM+M’s 2025 40 Under 40 list. MM+M’s annual 40...

PHR : 20.29 (-1.27%)
Phreesia Named to the 2025 Deloitte Technology Fast 500™

Phreesia, a leader in patient intake, outreach and activation, has been named to the 2025 Deloitte Technology Fast 500™ . Now in its 31st year, the prestigious list ranks the 500 fastest-growing...

PHR : 20.29 (-1.27%)
Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2026 financial results after the close of market trading on Monday, Dec. 8, 2025. Phreesia will...

PHR : 20.29 (-1.27%)
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling

Phreesia, a leader in patient intake, outreach and activation, has been named to the 2025 Capterra Shortlists in the Appointment Reminder and Appointment Scheduling categories....

PHR : 20.29 (-1.27%)
Becker’s Names Phreesia’s Sara DiNardo as one of 2025’s Rising Stars of Healthcare

Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sara DiNardo, Vice President of Client Solutions, has been named in Becker’s Hospital Review ’s...

PHR : 20.29 (-1.27%)
Phreesia: Fiscal Q2 Earnings Snapshot

Phreesia: Fiscal Q2 Earnings Snapshot

PHR : 20.29 (-1.27%)
Phreesia Announces Second Quarter Fiscal 2026 Results

Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. “I am proud to share that Phreesia has had many...

PHR : 20.29 (-1.27%)
Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions

Phreesia, Inc. (NYSE: PHR) (“Phreesia”), a trusted leader in patient activation, today announced it has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. (together with...

PHR : 20.29 (-1.27%)
Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare

New offering enhances Phreesia’s existing platform, eliminating long hold times and ensuring every patient call is resolved

PHR : 20.29 (-1.27%)
Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street

Phreesia, a leader in patient intake, outreach and activation that enables one in seven patient visits across the U.S., and Sesame Workshop, the global nonprofit behind Sesame Street , are...

PHR : 20.29 (-1.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based...

See More

Key Turning Points

3rd Resistance Point 21.46
2nd Resistance Point 21.20
1st Resistance Point 20.74
Last Price 20.29
1st Support Level 20.02
2nd Support Level 19.76
3rd Support Level 19.30

See More

52-Week High 32.76
Fibonacci 61.8% 27.33
Fibonacci 50% 25.65
Fibonacci 38.2% 23.98
Last Price 20.29
52-Week Low 18.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar